Skip navigation

AbbVie Inc.

Pharmaceuticals
United States
2016 Revenue (US$ Millions)$25,638
Revenue Growth (%)12.16%
Net Income (US$ Millions)$5,953
Earnings Per Share (US$)$3.63
EPS Growth Rate (%)15.97%
Profit Margin23.22%
Total Equity (US$ Millions)$4,636
Return on Equity (%)150.90%
Long Term Debt (US$ Millions)$36,440
Debt To Equity Ratio (%)7.86%
Total Assets (US$ Millions)$66,099
Current Assets (US$ Millions)$16,187
Current Liabilities (US$ Millions)$9,781
Cost of Goods Sold (US$ Millions)$5,833
Inventory Turnover3.69